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Objective: To report the prevalence and to identify factors predictive of intraocular infection
in patients with fungemia receiving prophylactic antifungal therapy.
Methods: A retrospective review of patients who received prophylactic antifungal therapy and
a dilated fundus examination at an academic urban tertiary care center from 2000 to 2007. Basic
demographic information, fungal species grown, antifungal agent(s) used, number of positive
blood culture specimens, visual acuity, visual symptoms, and known risks of disseminated candidiasis were noted. Logistic regression analysis was used to determine the factors significantly
associated with intraocular fungal infection.
Results: A total of 132 patients with positive fungemia culture were requested to have ophthalmology consults. The prevalence of ocular infection was 6.9% (N=9). All nine patients were infected
with Candida species. Undergoing gastrointestinal (GI) surgery within the prior 6 months was
significantly related to developing intraocular infection, with an odds ratio of 18.5 (95% confidence
interval, 15.1–24.3; P=0.002). Having $3 positive fungal blood cultures was also a significant risk
factor, with an odds ratio of 2.6 (95% confidence interval, 1.8–3.7; P=0.03). Among 40 patients
having GI surgery, eight (20.0%) had intraocular fungal disease, compared with one of 92 patients
(1.1%) not having GI surgery. Among 125 patients with a negative baseline examination result,
two of 32 patients (6.3%), who had recent GI surgery, subsequently developed fungal ocular
disease, compared with 0 of 93 patients (0%), who did not have recent GI surgery.
Conclusion: Recent GI surgery and higher numbers of positive fungal blood culture specimens
may be predictive of candida ocular infections. Normal baseline fundoscopy examination results
in patients with such risks may require repeat evaluations to detect delayed manifestations.
Keywords: fungal chorioretinitis, fungal endophthalmitis, risks factors for intraocular fungal
infection, risks of gasterointestinal surgery
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One of the most common inpatient ophthalmology consults is for the fundoscopic
evaluation of patients with fungemia.1,2 Candida species, in particular, are the fourth
most common organisms identified on microbial blood stream infections in temperate
climates of the USA and Europe.3–5 Some of the major risk factors for the development
of candidemia are immunosuppression, indwelling catheters, total parenteral nutrition,
and intravenous drug abuse.6–8 Ocular infection from fungemia is uncommon, but if
present, permanent vision loss may result depending on the location and extent. The
current recommendation from the Infectious Disease Society of America (IDSA) is to
provide at least one dilated fundus examination to patients with positive fungal blood
cultures.9 Chorioretinitis and endophthalmitis are the most common manifestations
of fungemia in the eye.2,3,6 These entities were more prevalent before the widespread
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use of prophylactic antifungal therapy, quicker laboratory
detection of fungemia, and newer generation agents with
greater efficacy and better side-effect profiles.10–12
A positive ophthalmic examination result in patients
with fungemia, in addition to facilitating management of
secondary ocular complications, establishes the diagnosis
of disseminated candidiasis.1 However, the utility of routine
ophthalmology consultation to rule out ocular involvement
in patients with fungemia has been challenged by many
authors.8,11,13–15 Although formal cost-effectiveness analyses
on this issue are lacking, there is an increasing sentiment
expressed in the ophthalmic literature to change the criteria
by which an ophthalmology evaluation is requested for
inpatients with fungemia.13,15
The reliance of visual symptoms alone results in a
poor sensitivity (28.6%) and poor positive predictive value
(26.7%) as the majority of patients with ocular infection may
have no symptoms or external signs.13 The problem of relying on symptoms and external signs is compounded when
patients are preverbal or unresponsive due to intubation or
other medical comorbidities.8–10
With respect to patients with fungemia and specifically candidemia, there may be a subset of risk factors that
increases the likelihood of detecting intraocular infection.
Since the prevalence of disease affects pretest likelihood, a
determination of the local prevalence of endogenous ocular
fungal infections would be necessary to guide any changes
to the screening algorithm of patients with fungemia.16
Our aims for this study were twofold: 1) to report the prevalence of endogenous fungal chorioretinitis/endophthalmitis
among patients with fungemia and 2) to determine what risk
factors among patients with fungemia place them at greater
odds of having intraocular infection.

Methods
This study was a retrospective review conducted at the
Virginia Commonwealth University (VCU) Medical Center
between 2000 and 2007 that enrolled all inpatients consulted
by the ophthalmology department to rule out ocular fungal
infections. Consult sheets, electronic records, laboratory
results, discharge summaries, and billing statements were
reviewed. Patients with any prior ocular surgery, prior ocular trauma, and negative fungemia culture results, despite
external candidal infections (ie, oral or urine infections),
were excluded from participation. This study was approved
by the VCU Office of Research Subjects Protection and was
in accordance with the Declaration of Helsinki.
All abnormal fundoscopic examinations were confirmed
by a faculty member who had undergone training in a
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vitreoretinal fellowship. Visual acuity was assessed with
standard near cards at the bed side or Snellen charts in the
clinic. In preverbal children, it was recorded whether or not
they could fix and follow. When patients were intubated,
sedated, or both, vision was recorded as unable to assess.
An anterior segment examination was done with an external
light source (eg, indirect ophthalmoscope with 20D lens),
portable slit lamp, or mounted slit lamp in clinic. All dilated
fundus examinations were performed with indirect ophthalmoscopy. The diagnosis of fungal chorioretinitis was based
on the description of Donahue et al11 as a deep focal, fluffy
white lesion in the chorioretinal layers. Endophthalmitis was
defined as vitreous involvement and further anterior extension with fluffy vitreous balls, vitreous haze, vitreous abscess,
anterior chamber cells, or hypopyon. Basic demographic
information was gathered along with fungal species grown,
antifungal agent(s) used, number of positive blood culture
specimens, visual acuity, and visual symptoms. Further, we
documented historically reported risk factors (HRRF)6–8 for
candidemia such as broad spectrum antibiotic use, gastrointestinal (GI) surgery within the previous 6 months, generalized immunosuppression, intravenous drug abuse, indwelling
intravenous catheters, parenteral hyperalimentation, and
multiple-organ involvement.
For the purposes of this study, GI surgery consisted
of incisional surgery anywhere from the oral cavity to the
anus as well as endoscopic procedures of this area. Etiologies of immunosuppression consisted of being on chronic
corticosteroid therapy, routine use of immunosuppressive
agents in patients posttransplant or with autoimmune conditions, chemotherapeutic agents, and infection with HIV.
Further, diabetes mellitus was also considered as a form
of immune suppression. VCU Medical Center follows the
recommendations of the IDSA and the Surgical Infection
Society,17 regarding acquisition of specimens for potential
blood stream infections, obtaining 20–30 mL of blood with
2–3 bottles. If multiple sites were used to gather samples,
they were all accessed within 1 hour of each other. If one
of the samples was obtained from a venous catheter, then a
separate bottle was also needed from a venipuncture site as
the risk of contamination is higher for indwelling venous
lines. Patients older than 2 months of age had the venipuncture site disinfected with chlorhexidine or 2% iodine
tincture. Changes in the clinical picture of the patient may
have resulted in repeat blood culture sampling, which is how
some patients in this study could have had more than three
bottles of blood sampled.
Besides determining the prevalence of ocular fungal infection in our population, we performed a logistic
Clinical Ophthalmology 2015:9
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regression analysis to determine the possible risk factors that
would impact the odds of having ocular involvement. The
dependent variable was the presence of intraocular fungal
infection (fungal chorioretinitis/endophthalmitis), and the

independent variables were the demographic factors (Table 1)
and the HRRF for disseminated candidemia.6–8 One variable
was added to the model, besides the above, the proportion
of blood culture positive specimens obtained. With these

Table 1 Patient characteristics
N=123 (%)
Sex
Men
72 (58.5)
Women
52 (41.5)
Age, ± standard deviation (years)
37.3±25.2
45.6±19.8
Age after exclude those #20 years old, none of
whom had ocular fungal infection
Race
White
49 (39.8)
Black
64 (52.0)
Other
10 (8.1)
Visual acuity (near, best corrected)
N = number of eyes; 247 (%)
20/20–20/40
104 (42.1)
20/50–20/200
38 (15.4)
4 (1.6)
.20/200
Fixes and follows
24 (9.7)
Unable to assess
77 (31.2)
Visual symptoms (floaters, photopsias, pain, and conjunctival injection)
Present
76 (30.8)
Absent
94 (38.1)
Unable to assess
77 (31.2)
Candida species grown
N=123 (%)
C. Albicans
50 (40.7)
C. Parapsilosis
30 (24.4)
C. Glabrata
22 (17.9)
C. Tropicalis
15 (12.2)
C. Lusitaniae
2 (1.6)
C. Krusei
2 (1.6)
Candida not otherwise specified
2 (1.6)
Prophylactic antifungal therapy useda
Amphotericin B
30 (24.4)
Caspofungin
48 (39.0)
Fluconazole
61 (49.6)
Voriconazole
13 (10.6)
Number using multiple antifungal agents
36 (29.2)
Risk factors for disseminated candidiasisa
Broad spectrum antibiotic use
98 (79.7)
Indwelling intravenous catheters
92 (74.7)
Gastrointestinal surgery within the last
32 (26.0)
6 months
Parenteral hyperalimentation
59 (47.9)
Generalized immunosuppression
63 (51.2)
Multiple-organ involvement
40 (32.5)
Intravenous drug abuse
2 (0.02)
Average number of positive blood culture
2.02
specimens per patient
Fraction of positive blood culture specimens
0.52
Intraocular pressure
14.01
Concomitant bacteremia
28 (22.6)
Number of nonocular surgeries in the past year
0.86

N=9 (%)

P-value

4 (44.4)
5 (55.6)
51.1±17.8
51.1±17.8

0.42
0.42
0.05
0.39

4 (44.4)
4 (44.4)
1 (11.1)
N = number of eyes; 17 (%)
8 (47.1)
4 (23.5)
0
0
6 (35.3)

0.75
0.66
0.79

4 (23.5)
10 (58.5)
3 (17.6)
N=9 (%)
6 (66.7)
0
2 (22.2)
1 (11.1)
0
0
0

0.74
0.09
0.24

1 (11.1)
4 (44.4)
5 (55.5)
1 (11.1)
2 (22.2)

0.36
0.75
0.73
0.96
0.65

8 (77.8)
7 (66.7)
8 (88.9)

0.89
0.59
,0.01

5 (55.5)
6 (66.7)
4 (44.4)
0
4.22

0.33
0.10
0.16
0.60
0.03

0.78
13.20
1 (11.1)
1.55

0.04
0.71
0.34
0.07

0.69
0.38
0.60
0.18
0.72

0.13
0.09
0.75
0.92
0.65
0.65
0.65

Notes: Columns with mutual exclusively may not round to 100% due to rounding errors. aThe following columns will not add to 100% since these items were not mutually
exclusive.

Clinical Ophthalmology 2015:9

submit your manuscript | www.dovepress.com

Dovepress

1855

Dovepress

Geraymovych et al

parameters defined, a backward selection technique was
used to select the most parsimonious model as nonsignificant
covariates were excluded. We also used multiple two-sided
independent t-tests to compare patients with ocular infection to those without. A significance of P,0.05 was used.
All statistical analyses were done with SAS 9.3 (2011 SAS
Institute Inc., Cary, NC, USA).

Results
A total of 132 patients with fungemia during the study period
had an inpatient evaluation by the ophthalmology department. Nine of 132 patients (6.9%) had intraocular fungal
infection. Five of these nine were female patients. Four of the
nine were Black, four were White, and one was categorized
as “Other” (Table 1). The mean age of patients with ocular
infection was 51.1 years with a standard deviation of 16.8.
Seven patients had bilateral chorioretinitis, one patient had
chorioretinitis of the left eye only, and another had bilateral
fungal endophthalmitis. All nine cases were infected with
Candida species and Candida albicans grew in six patients.
Caspofungin was used in four of the nine patients, and fluconazole was used in five. The patients on caspofungin were
either already on fluconazole or later changed to fluconazole,
upon the diagnosis of ocular candidiasis. The patient with
endophthalmitis died 4 weeks after detection, and a patient
with bilateral chorioretinitis died 8 weeks after detection. Four
patients resolved with antifungal therapy alone, and three
patients were lost to follow-up. None of the patients received
intravitreal antifungal therapy or pars plana vitrectomy. Two
of nine patients had normal baseline examination results and
went on to develop positive fundoscopic findings for candidal
involvement within 14 days. Both had recent GI surgery. In
one of these two patients, a repeat examination was requested
11 days later for bilateral photopsias, which ended up yielding evidence of bilateral chorioretinitis. The other patient
remained asymptomatic, and positive examination findings
were found on routine outpatient examination 14 days after

baseline examination. Only one other patient with ocular
fungal disease was symptomatic, also complaining of bilateral
photopsias but had a positive baseline examination.
A significantly greater proportion of patients with
endogenous candidal ocular infection had recent GI surgery
compared to those without ocular infection (88.9% vs 26.0%,
P,0.01). Compared to patients without fungal eye disease,
the mean fraction of positive blood culture specimens was
significantly higher among patients with fungal eye disease
(0.78 vs 0.52, P=0.04). Some differences between those with
ocular infection compared to those without ocular involvement approached significant levels, such as the number of
nonocular surgeries (1.55 vs 0.86, P=0.07) and generalized
immune suppression (66.7% vs 51.2%, P=0.10). C. albicans
represented 40.7% of the species among patient without
intraocular infection and 66.7% of patients with intraocular
infection. However, the type of Candida species did not
impact the risk of developing ocular infection (Tables 1
and 2). Fluconazole was used in 66 of 132 of our patients, yet
the type of antifungal agent used in patients with fungemia
did not significantly impact the development of intraocular
fungal infection. In the logistic regression analysis, only three
factors significantly affected the fit of the model regarding
the presence of ocular fungal infection (Table 2). Patients
who had undergone GI surgery within the last 6 months were
at an 18.5 times higher odds of developing ocular fungal
infection compared to those who did not have GI surgery
in the last 6 months (P=0.002). Patients who had grown $3
positive blood culture specimens were at a 2.6 times higher
odds of developing ocular fungal infection compared to
those with #2 positive specimens (P=0.03). The fraction of
positive blood culture specimens was also associated with
the presence of ocular fungal infection. When three-quarters
or more of the blood cultures were positive, the odds of having ocular candidal infection were more than twice as high
(P=0.04). None of the remaining HRRF for candidiasis had
an impact on intraocular candidal infection.

Table 2 Factors impacting ocular Candida infection in the multivariate logistic regression model
Gastrointestinal surgery
None in prior 6 months (reference)
One or more in the prior 6 months
Number of positive Candida blood cultures
#2 (reference)
$3
Fraction of positive blood culture specimens
,0.75 (reference)
$0.75

Odds ratio (95% confidence intervals)

P-value

–
18.5 (15.1–24.3)

–
0.002

–
2.6 (1.8–3.7)

–
0.03

–
2.4 (1.2–3.1)

–
0.04

Notes: Odds ratios and 95% confidence intervals for the covariates associated with an increased risk of intraocular fungal infection. P-values are from the χ2 tests.
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Discussion
In accordance with the recommendations of the IDSA, all
patients with fungemia at our institution receive at least one
dilated eye examination.9 Moreover, some reports state that up
to 18% of ocular candidal infections have negative baseline fundoscopy examinations.18 The time from a negative fundoscopy
examination to visible ocular fungal lesions has ranged from
8 days to several weeks.19–21 Given the chance of delayed presentation, we repeat a dilated fundus examination at 4–6 weeks
if the baseline fundoscopy examination is negative.
The prevalence of ocular fungal infection in our population
was 6.9%. All cases were from Candida species. Although this
figure is higher than some recent studies, this prevalence seems
to be in line with several contemporary reports that demonstrate
values from 2% to 16%.1,2,8,12,15,22,23 The prevalence of current
reports is lower than historical reports (35%–45%).19,24–26
This is largely due to the initiation of prophylactic antifungal
therapy for all positive blood cultures.15,19,22–26
Many authorities are questioning the utility of ophthalmic
examination for patients with fungemia since now there is
quicker laboratory detection of fungal blood specimens prompting the use of antifungal agents, which have greater efficacy
and better side-effect profiles compared to decades ago.8,11,13–15
Furthermore, some authors assert that patients with endogenous
spread of fungal disease to the eye are at higher risk of mortality, and an ocular examination may add to the cost of end of
life care. Oude Lashof et al12 reported the 14-week mortality of
patients with endogenous candidal endophthalmitis to be 50%,
while that in ocular candidiasis, which was not classified as
endophthalmitis, was 43.3%. The latter values were not significantly higher than the 14-week mortality rate for patients with
candidemia but without ocular infection, 36.5% (P=0.31).
Moreover, because of these advances along with the
higher mortality among patients with fungemia, the management is reported to rarely change even after fundoscopic
evidence of ocular infection. Ghodasra et al13 estimated that
an average of 26.4 patients with fungemia would need to
be evaluated, at an average cost of 5,620.33 US Dollars per
patient, in order to find one needing a change in management.
This money value was based on the Centers of Medicare and
Medicaid Services 2014 Physician Fee Schedule.27 These
authors, among many others, are reassessing the utility of
fundoscopic examinations for patients with fungemia.
However, given the potentially negative visual outcome of
intraocular fungal infections, eliminating the need for fundoscopic examinations altogether may be premature. Perhaps, there
are a unique set of risk factors that would raise the pretest likelihood, or better stated, the pre-fundoscopy examination likelihood
of a patient with candidemia to have ocular involvement.
Clinical Ophthalmology 2015:9
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Our study demonstrated that of the HRRF, only recent
GI incisional or endoscopic surgery was significantly associated with ocular candidal infection (odds ratio, 18.5; 95%
confidence interval, 15.1–24.3; P=0.002). It is possible that
Candida species that are commensal with the GI tract could
gain access to the blood stream in high enough inoculations
to cause systemic disease.
A higher number of positive candidal blood culture
specimen bottles also strongly correlated with the presence
of intraocular infection. Having $3 positive culture bottles
increased the odds of ocular infection compared to those
with #2 positive culture bottles. Greater numbers of positive
culture specimens may be a marker for larger fungal inoculation, or in the circumstance of delayed specimen collection by
a few days, it could represent a virulent organism and/or an
immunocompromised host. This may predispose the patient to
disseminated fungal disease. The fraction of positive culture
bottles can also be understood by the above statements.
There are several noteworthy limitations to our study.
First, only patients suspected of having abnormal fundus
examinations based on an evaluation by a resident ophthalmologist were subjected to a confirmatory examination by
a vitreoretinal specialist. It is possible that patients deemed
as having normal fundus examinations may have had subtle
retinal lesions that a novice examiner may have overlooked.
Although our policy was to have outpatient follow-up for
inpatients not seen by an attending physician, not all patients
were able to make such appointments.
Second, many patients with fungemia, especially those
with disseminated disease, may be in critical condition. It is
possible that we did not evaluate all patients with fungemia as
they may have had significant comorbidities that took precedence over ophthalmic consultation or were deceased before
such consultation could take place. These patients by virtue
of their aggressive disease could have been significantly
different from the patients who had been evaluated by the
ophthalmology service. Finally, the nature of retrospective
investigations lends itself to inconsistencies in documentation, which leads to suboptimal data entry for analysis.
In conclusion, this study demonstrated the prevalence of
intraocular infection to be 6.9% among patients with fungemia
in our urban academic medical center. Many clinicians are
reevaluating the utility of inpatient ophthalmology consults on
patients with fungemia. However, we feel that missing positive
cases increases the risk of morbidity to the eye, especially in
cases of asymptomatic endophthalmitis, and mortality to the
patient13 by missing the chance to establish a diagnosis of disseminated candidiasis. The presence of certain risk factors may
raise the likelihood of a patient with fungemia, and candidemia
submit your manuscript | www.dovepress.com
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in particular, of having ocular infection. This study showed
that patients having GI surgery within the last 6 months, having $3 positive candida blood culture specimens, and having
positive Candida blood cultures in $0.75 of specimens collected, may all increase the risk of ocular candidal infection,
and thereby warrant greater scrutiny. When patients with such
risk factors have negative baseline fundoscopic examinations,
ophthalmologists may wish to perform repeat examinations
within 2 weeks to detect delayed onset disease as is the current
practice at our institution. For patients without such risks, the
need for repeat fundoscopic examinations may continue to be
at the discretion of the clinician on a case-by-case basis. Lastly,
prospective research is necessary to determine which other
risk factors are significantly associated with ocular infection,
thus may be identified as predictive factors and may better
guide clinical decision-making when reconsidering screening
algorithms for patients with fungemia.
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